Sector Chart Arrowhead Pharmaceuticals, Inc.

Equities

ARWR

US04280A1007

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 15:21:25 23/01/2026 GMT			5-day change	1st Jan Change
70.70 ^USD	+1.59%		+10.41%	+6.17%

01-22	B. Riley Raises Price Target on Arrowhead Pharmaceuticals to $101 From $61, Keeps Buy Rating	MT
01-13	Aligos Therapeutics, Inc. Appoints James Hassard as Executive Vice President and Chief Commercial Officer, Effective January 13, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	P/E
ARROWHEAD PHARMACEUTICALS, INC.	9.56B	-
ARGENX SE	50.26B
WUXI APPTEC CO., LTD.	41.75B
INSMED INCORPORATED	34.21B	-
BIONTECH SE	29.73B	-
WUXI BIOLOGICS (CAYMAN) INC.	20.65B